BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, in collaboration with leading ALS research centers, today announced the acceptance of new ...

Prilenia Therapeutics has signed a partnership and licence agreement with Ferrer to jointly develop and commercialise ...